Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 May;65(5):e61-e66.
doi: 10.1111/epi.17961. Epub 2024 Mar 20.

Racial disparities in the utilization of invasive neuromodulation devices for the treatment of drug-resistant focal epilepsy

Juan Luis Alcala-Zermeno  1   2 , Brandy Fureman  3 , Caitlin L Grzeskowiak  3 , Ojas Potnis  3 , Maria Taveras  4 , Margaret W Logan  3 , Delanie Rybacki  3 , Daniel Friedman  4 , Daniel Lowenstein  5 , Ruben Kuzniecky  6 , Jacqueline French  3   4 ; HEP2 investigators
Affiliations
Multicenter Study

Racial disparities in the utilization of invasive neuromodulation devices for the treatment of drug-resistant focal epilepsy

Juan Luis Alcala-Zermeno et al. Epilepsia. 2024 May.

Abstract

Racial disparities affect multiple dimensions of epilepsy care including epilepsy surgery. This study aims to further explore these disparities by determining the utilization of invasive neuromodulation devices according to race and ethnicity in a multicenter study of patients living with focal drug-resistant epilepsy (DRE). We performed a post hoc analysis of the Human Epilepsy Project 2 (HEP2) data. HEP2 is a prospective study of patients living with focal DRE involving 10 sites distributed across the United States. There were no statistical differences in the racial distribution of the study population compared to the US population using census data except for patients reporting more than one race. Of 154 patients enrolled in HEP2, 55 (36%) underwent invasive neuromodulation for DRE management at some point in the course of their epilepsy. Of those, 36 (71%) were patients who identified as White. Patients were significantly less likely to have a device if they identified solely as Black/African American than if they did not (odds ratio = .21, 95% confidence interval = .05-.96, p = .03). Invasive neuromodulation for management of DRE is underutilized in the Black/African American population, indicating a new facet of racial disparities in epilepsy care.

Keywords: deep brain stimulation; epilepsy surgery; inequity; responsive neurostimulation; vagus nerve stimulation.

PubMed Disclaimer

References

REFERENCES

    1. Jobst BC, Cascino GD. Resective epilepsy surgery for drug‐resistant focal epilepsy: a review. JAMA. 2015;313:285–293.
    1. Ryvlin P, Rheims S, Hirsch LJ, Sokolov A, Jehi L. Neuromodulation in epilepsy: state‐of‐the‐art approved therapies. Lancet Neurol. 2021;20:1038–1047.
    1. Hamade YJ, Palzer EF, Helgeson ES, Hanson JT, Walczak TS, McGovern RA. Persistent racial and ethnic disparities as a potential source of epilepsy surgery underutilization: analysis of large national datasets from 2006–2016. Epilepsy Res. 2021;176:106725.
    1. Burneo JG, Black L, Knowlton RC, Faught E, Morawetz R, Kuzniecky RI. Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology. 2005;64:50–54.
    1. Fox J, Lekoubou A, Bishu KG, Ovbiagele B. Recent patterns of vagal nerve stimulator use in the United States: is there a racial disparity? Epilepsia. 2019;60:756–763.

Publication types

LinkOut - more resources